FAIL (the browser should render some flash content, not this).
   
   
     
     
   
     
   
LineaGen, Inc. is a content-based biomarker discovery company focused on the commercialization of novel, patentable diagnostic tests that will enable highly effective personalized medicine and healthcare in a variety of key areas. By using individuals' genetic profiles to diagnose health issues and conditions earlier and more accurately, LineaGen diagnostics will support early treatment and greatly improve patients' chances for positive results. be able to reliably predict those individuals' response to various treatments. One of LineaGen's core competitive advantages is its access to an unmatched biomarker discovery research platform that has been used to help the University of Utah identify more disease-related genes than any other institution in the world. LineaGen is working to develop a diversified portfolio of novel biomarkers for the development of new diagnostic tests, and to strategically license its intellectual property to commercial partners for the development of new therapeutic treatments.

© 2007 LineaGen